MÃ¥rten Steen
chairman
management
Strongbridge Biopharma
Sweden
Biography
Mårten has served as a member of our board of directors since December 2014. Since April 2010, he has served as a partner of HealthCap VI LP, a venture capital firm investing in life science companies. Prior to HealthCap, he served as director at Merck Serono SA, a biopharmaceutical company. Mårten currently serves on the board of directors of Wilson Therapeutics AB, Altimmune Inc., and BioClin Therapeutics Inc. He previously served on the board of directors of Ultragenyx Inc. and FerroKin Biosciences. Mårten holds an MD and a PhD in clinical chemistry and a BSc in business administration, all from Lund University.
Research Interest
Mårten holds an MD and a PhD in clinical chemistry and a BSc in business administration, all from Lund University.
